Results 61 to 70 of about 29,316 (170)
The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer [PDF]
, 2009 Background and objective Brain metastases are common in non-small-cell lung cancer (NSCLC) and the prognosis is poor. Erlotinib is a specific inhibitor of the epidermal growth factor receptor-associated tyrosine kinase (EGFRTKI), which has been gradually
Baohui HAN, Hao BAI
core
Huli yanjiu, 1999 静脉输注化疗药物是临床上治疗恶性肿瘤的常用方法之一，而大多数化疗药物在静脉输注过程中会造成血管内膜损伤，导致静脉炎，甚至局部坏死。但有关化疗药物致静脉损伤的病理变化方面的研究，国内外报道较少。现将对常用化疗药物致兔耳缘静脉损伤的病理变化的实验研究报告...
陈一芬 +7 more
doaj
The Role of Postoperative Radiotherapy on Stage N2 Non-small Cell Lung Cancer [PDF]
, 2009 Background and objective The clinical value of postoperative radiotherapy (PORT) in stage N2 nonsmall-cell lung cancer (NSCLC) is controversy. The aim of this study is to analyze the efficacy of PORT in subgroup of stage N2 NSCLC, which can help ...
Changli WANG +7 more
core
Zhongshan Daxue xuebao. Yixue kexue ban, 2014 【目的】 初步评价肝动脉灌注化疗联合局部内生场热疗（热化疗）在肝门部胆管癌治疗的临床应用价值。【方法】对２００３年１０月至２０１３年６月期间３９例接受介入治疗的肝门部胆管癌病人进行回顾性研究，其中热化疗组２０例，于肝动脉置管，灌注吉西他滨后，再行肝动脉持续灌注卡铂及肿瘤区域内生场热疗６０ｍｉｎ，热化疗后连续肝动脉灌注５－Ｆｕ ３ ｄ，第８天静脉应用吉西他滨１次。对照组１９例，肝动脉置管及化疗方案同前，未行热疗。上述治疗每４周为１疗程。化疗期间观察化疗毒副反应、并发症及耐受性 ...
doaj
Huli yanjiu, 2008 摘要： （免费在线浏览）摘要:［目的］观察穴位敷贴缓解化疗病人胃肠道反应的疗效。［方法］将2006年3月―2007年5月我院收治的化疗病人90例随机分为实验组和对照组，各45例，两组均 常规应用甲氧氯普胺10 mg肌肉注射，每日1次，时间为化疗当天至化疗结束。实验组在化疗前2 d至化疗结束后2 d在双侧内关等穴位给予穴位敷贴，24 h更换1次。对照组则不使用穴位敷贴。比较两组病人胃肠道反应程度。［结果］实验组病人胃肠道反应程度明显低于对照组。［结论］使用穴位敷贴对缓解化疗病人胃肠道反应有一定疗效。
阅读全文：0
doaj
血清CA125、AFP表达与NSCLC 患者化疗效果的相关性
Zhongguo shiyan zhenduanxue, 2023 目的 观察非小细胞肺癌(NSCLC)患者血清糖类抗原125(CA125)、甲胎蛋白(AFP)水平与化疗效果之间的关系。方法 回顾性分析，采集四川大学华西广安医院2019年1月至2021年2月期间收治的250例NSCLC接受DDP化疗患者资料，分析血清CA125、AFP水平与NSCLC患者化疗效果的关系。结果 化疗结束时，有效203例，无效47例，无效组血清CA125、AFP高于有效组(P1 ...
刘利, 邓太兵, 唐藜
doaj
A Randomized Phase I/II Trial to Compare Weekly Usage with Triple Weekly Usage of Paclitaxel in Concurrent Radiochemotherapy for Patients with Locally Advanced Non-small Cell Lung Cancer [PDF]
, 2011 Background and objective Although the guidelines of the National Comprehensive Cancer Network of USA recommend that the standard therapy for locally advanced non-small cell lung cancer (LANSCLC) is concurrent chemoradiotherapy.
Anhui SHI +4 more
core
Effects of Recombinant Human Endostatin and Docetaxel on MMP and its Following Anti-neoplastic Effect under Different Administration Sequences [PDF]
, 2010 Background and objective The aim of this study is to observe the changes of MMP-2 and its regulators, and to investigate the mechanism of the two administration sequences of recombinant human endostatin (rh-endostatin) and docetaxel.
Jing YUAN, Kai LI
core
Zhongguo shiyan zhenduanxue, 2017 胃癌是胃粘膜上皮的恶性肿瘤,其发病率和死亡率都位于第三位的恶性肿瘤。而且胃癌的发病年龄无局限性,胃癌的发病年龄常见于40-60岁[1]。现阶段胃癌的治疗方法主要是手术切除,之后化疗辅助治疗。顺铂为传统化疗药物,其与DNA交联诱导双链断裂而引起损伤,发挥其毒性作用,应用在胃癌化疗的不同时段,如辅助化疗的ECF方案,姑息化疗的DCF方案和分子靶向治疗的PF ...
张鑫, 张迪, 饶艳伟, 宋晓斌
doaj
Survival Analysis of 1,742 Patients with Stage IV Non-small Cell Lung Cancer [PDF]
, 2011 Background and objective At present non-small cell lung cancer (NSCLC) is still the leading cause of death induced by cancer. The aim of this study is to investigate the prognostic factors of advanced NSCLC.
Baohui HAN, Hong PENG, Meili MA
core